A matrix approach to diagnose MDR-TB in children†.
AP, anteroposterior; IGRA, interferon gamma release assay; MDR-TB,
multidrug resistant tuberculosis; TST, tuberculin skin test.
†Start at level 1 and obtain as much information as possible
to fill the pieces. The more level 1 and 2 pieces that fit together, the
more secure the MDR-TB diagnosis; concept adapted from Seddon J.
International Child TB training course, Desmond Tutu TB centre
Stellenbosch University, 2018.
*Provide treatment based on the drug susceptibility testing results of
the likely source case, if no guidance is available from the child’s own
specimens. The decision to treat should balance the likelihood of active
disease and disease progression risk against the toxicity, cost and
inconvenience of treatment. The following definitions apply.
Possible MDR-TB: TB symptoms and/or signs and/or radiology and child not
improving after 2–3 months of first-line treatment or close contact with
a patient who died from TB or failed TB treatment.
Probable MDR-TB: TB symptoms and/or signs and/or radiology with
documented recent exposure to an infectious MDR-TB case.
Confirmed MDR-TB: MDR-TB strain isolated from a child.
^Computed tomography (CT), magnetic resonance imaging (MRI) and/or
positron emission tomography (PET) depending on clinical symptoms and
signs, as well as the cost, availability and radiation exposure of
different modalities.